Susan Jenks. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AfatinibAntibodies, Monoclonal, Humanized/administration & dosageAntibodies, Monoclonal, Humanized/pharmacologyAntineoplastic Combined Chemotherapy Protocols/pharmacologyAntineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Non-Small-Cell Lung/drug therapyCarcinoma, Non-Small-Cell Lung/metabolismCetuximabClinical Trials as TopicDrug CombinationsErbB Receptors/drug effectsErbB Receptors/geneticsErbB Receptors/metabolismErlotinib HydrochlorideGefitinibHumansLung Neoplasms/drug therapyLung Neoplasms/metabolismMolecular Targeted Therapy/methodsNational Cancer Institute (U.S.)Quinazolines/administration & dosageQuinazolines/pharmacologyUnited States
Substances： See more » Antibodies, Monoclonal, HumanizedDrug CombinationsQuinazolinesAfatinibErlotinib HydrochlorideEGFR protein, humanErbB ReceptorsCetuximabGefitinib
Year: 2014 PMID： 25421346 DOI： 10.1093/jnci/dju393
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506